Corvus Pharmaceuticals, Inc. Accounts Receivable, Related Parties, Current
Corvus Pharmaceuticals, Inc. (CRVS) had Accounts Receivable, Related Parties, Current of $429.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-08.
Discontinued › Notes
us-gaap:AccountsReceivableRelatedPartiesCurrent · last filed 2023-05-08
- 2023-03-31: Accounts Receivable, Related Parties, Current $429.00K.
- 2022-12-31: Accounts Receivable, Related Parties, Current $588.00K.
- 2022-09-30: Accounts Receivable, Related Parties, Current $503.00K.
- 2022-06-30: Accounts Receivable, Related Parties, Current $373.00K.
| Period end | Accounts Receivable, Related Parties, Current |
|---|---|
| 2023-03-31 | $429.00K 10-Q · filed 2023-05-08 |
| 2022-12-31 | $588.00K 10-Q · filed 2023-05-08 |
| 2022-09-30 | $503.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $373.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $373.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $507.00K 10-K · filed 2023-03-28 |
| 2021-09-30 | $276.00K 10-Q · filed 2021-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |